You are here

Marinus Pharmaceuticals to Present at the Leerink Healthcare Conference

RADNOR, Pa., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced that Christopher M. Cashman, Chief Executive Officer will present a company overview at the 8th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 27, 2019 at 3:00 p.m. ET.  The conference will take place in New York.
Wednesday, February 20, 2019 - 07:30